Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 10/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | PKM | P14618 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11048215 | 0.89 | MAPT (0.52) | ALDH1A1NPSR1MAPTL3MBTL1TDP1 | |
| SCHEMBL25341923 | 0.88 | ALDH1A1 (0.53) | ALDH1A1NPSR1MAPTL3MBTL1TDP1 | |
| SCHEMBL10896768 | 0.84 | MAPT (0.45) | ALDH1A1MAPTTDP1POLBMEN1 | |
| SCHEMBL10805579 | 0.84 | MAPT (0.62) | ALDH1A1NPSR1MAPTL3MBTL1TDP1 | |
| SCHEMBL8655505 | 0.83 | KAT2B (0.56) | ALDH1A1MAPTL3MBTL1TDP1POLB | |
| SCHEMBL1889528 | 0.83 | PKM (0.45) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| SCHEMBL10716987 | 0.82 | MAPT (0.48) | ALDH1A1NPSR1MAPTPOLBMEN1 | |
| SCHEMBL1136820 | 0.82 | MAPT (0.48) | ALDH1A1NPSR1MAPTL3MBTL1POLB | |
| SCHEMBL9657643 | 0.81 | GLA (0.42) | ALDH1A1NPSR1MAPTL3MBTL1TDP1 | |
| SCHEMBL11772632 | 0.81 | HTT (0.49) | ALDH1A1MAPTTDP1POLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1919439-A2 | PROCESS FOR BLEACHING KERATIN FIBERS | The Procter and Gamble Company (US) | 2008-05-14 | — | — | EP | claimed |
| US-20070231283-A1 | Process for bleaching keratin fibers | PROCTER & GAMBLE COMPANY, THE | 2007-10-04 | — | — | US | claimed |
| WO-2007026327-A2 | PROCESS FOR BLEACHING KERATIN FIBERS | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | claimed |
| EP-1759684-A1 | Process for bleaching keratin fibers | Wella Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | claimed |
| WO-2006108458-A1 | AGENTS FOR SIMULTANEOUSLY DYING AND LIGHTENING KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-10-19 | — | — | WO | claimed |
| US-20050257328-A1 | Agent for simultaneously dying and bringhtening keratin fibers | WELLA AKTIENGESELLSCHAFT (DE) | 2005-11-24 | — | — | US | claimed |
| EP-2387988-B1 | Oxidizing composition for the treatment of keratin fibres | PROCTER & GAMBLE (US) | 2017-09-27 | — | — | EP | disclosed |
| US-9499419-B2 | Methods and compositions for treatment of skin | Special Waters Patents B.V. (NL) | 2016-11-22 | — | — | US | disclosed |
| US-8444706-B2 | Oxidizing composition for the treatment of keratin fibers | THE PROCTER & GAMBLE COMPANY (US) | 2013-05-21 | — | — | US | disclosed |
| CN-102892402-A | Oxidizing composition for the treatment of keratin fibers | PROCTER & GAMBLE | 2013-01-23 | — | — | CN | disclosed |
| US-20120288459-A1 | Oxidizing Composition for the Treatment of Keratin Fibers | BURG WILFRIED (DE) | 2012-11-15 | — | — | US | disclosed |
| US-8308822-B2 | Oxidizing composition for the treatment of keratin fibers | THE PROCTER & GAMBLE COMPANY (US) | 2012-11-13 | — | — | US | disclosed |
| EP-1972330-B1 | Cosmetic or pharmaceutical compositions comprising modified polysiloxanes with at least one carbamate group | CLARIANT FINANCE BVI LTD (VG) | 2012-09-12 | — | — | EP | disclosed |
| WO-2005083009-A1 | CATIONIC HETEROARYL AZINE DYES, AND DYEING AGENTS CONTAINING SAID COMPOUNDS | WELLA AKTIENGESELLSCHAFT (DE) | 2005-09-09 | — | — | WO | disclosed |
| WO-2005079732-A1 | HAIR DYE FOR DYEING AND LIGHTENING KERATIN FIBERS | WELLA AKTIENGESELLSCHAFT (DE) | 2005-09-01 | — | — | WO | disclosed |
| WO-2005080507-A1 | LIGHTENING COLORANT CONTAINING INDOLYL THIAZOLIUM AZO DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2005-09-01 | — | — | WO | disclosed |
| WO-2005075574-A1 | NEUTRAL AND CATIONIC NAPHTHALENE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS FOR DYEING KERATIN FIBERS | WELLA AKTIENGESELLSCHAFT (DE) | 2005-08-18 | — | — | WO | disclosed |
| WO-2005075481-A1 | NOVEL NAPHTHALENE DERIVATIVES AND COLORING AGENTS CONTAINING THESE COMPOUNDS, FOR KERATIN FIBERS | WELLA AKTIENGESELLSCHAFT (DE) | 2005-08-18 | — | — | WO | disclosed |
| EP-1555012-A1 | Hair dyeing composition containing anthraquinones | Clariant GmbH (DE) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004078150-A1 | AGENT FOR SIMULTANEOUSLY DYING AND BRIGHTENING KERATIN FIBERS | WELLA AKTIENGESELLSCHAFT (DE) | 2004-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120288459-A1 | Oxidizing Composition for the Treatment of Keratin Fibers | KRT18, CKMT1A; CKMT1B, OAT | ALDH1A1 1192/4885NPSR1 3480/4885MAPT 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.